Vyaderm Pharmaceuticals: The EVA Decision - Case Solution
Robert L. Simons and Indra A. Reinbergs | Harvard Business Review ( 101019-PDF-ENG ) | October 04, 2000 (Revision: 2023-09-09)
Abstract:
The Vyaderm Pharmaceuticals: The EVA Decision case study allows students to calculate the EVA (Economic Value Added) for a company as well as the bonus for the head of the Dermatology division.
Case Questions Answered
- Calculate the EVA (Economic Value Added) for Vyaderm Pharmaceuticals Dermatology Division.
- Calculate the bonus for the head of the Dermatology division.
This case solution includes an Excel file with calculations that will be available after purchase.
This case solution includes an Excel file with calculations.
1. Calculate the EVA (Economic Value Added) for Vyaderm Pharmaceuticals
Dermatology Division.
The EVA calculation for the Dermatology Division of Vyaderm Pharmaceuticals is illustrated below:
Preview Only — Unlock Full Content Below
Complete Case Solution
Get immediate access to the full, detailed analysis
- Comprehensive answers to all case questions
- Detailed analysis with supporting evidence
- Instant digital delivery (PDF format)
Buy Full Case Solution
Secure payment • Instant access
By clicking, you agree to our Terms of Use, Arbitration and Class Action Waiver Agreement and Privacy Policy